Purpura - 88 Studies Found
| Completed |
: SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) : Purpura, Thrombocytopaenic, Idiopathic : 2005-02-01 : Drug: SB497115 |
| Completed |
: High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) : Purpura, Thrombocytopenic, Idiopathic : 2011-05-17 :
|
| Withdrawn |
: A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia. : Purpura, Thrombocytopaenic, Idiopathic : 2011-09-22 :
|
| Completed |
: Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia : Purpura, Thrombocytopenic, Idiopathic : 2015-01-06 :
|
| Withdrawn |
: Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia : Purpura, Thrombocytopenic, Idiopathic : 2011-03-17 : Drug: rhIL-11 Recombinant Human Interleukin-11 (rhIL-11) Combinating Low-dose Rituximab |
| Completed |
: The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia. :
|
| Withdrawn |
: Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura : Purpura, Thrombotic Thrombocytopenic : 2012-12-12 :
|
| Terminated |
: IdeS in Asymptomatic Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients : Purpura, Thrombotic Thrombocytopenic : 2016-07-27 : Biological: HMed-IdeS One dose of 0.25 mg/kg BW HMed-IdeS on study day 0. Following and evaluation of ef |
| Completed |
: Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura : Thrombotic Thrombocytopenic Purpura : 2009-05-22 : Drug: rituximab Patients will be treated according to the recommendations of the Reference Centre for th |
| Active, not recruiting |
: Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP) : Thrombotic Thrombocytopenic Purpura : 2008-07-09 :
|